|
|||||
|
Updated: Part IIThe precise tasks of the Commission are set out in the Terms of Reference. Broadly speaking, the Commission is to find out why there were a high number of different results when certain hormone receptor tests, done between 1997 and 2005, were retested. The Commission is also to examine the response of authorities when the problems were discovered, including the communications with affected patients and others. Further, the Commission is to study present practices related to estrogen and progesterone receptor testing. In addition, there is what can be described as a policy development role for the Commission. Term (f) directs that recommendations be made as to how matters of this nature should be handled. Though not exclusively, Part II will be largely directed to providing information to the Commission which would assist in making such recommendations. To that end, six experts have been engaged to prepare papers. The papers, which are directed to aspects of the obligation to disclose, will be posted on the website in March, 2008. Those preparing papers and the general nature of the topics to be discussed are listed below. Biographical information respecting the authors is also available. These topics will also be discussed at a symposium to be held in St. John's on April 22 and 23, 2008. Mr. Timothy Caulfield, Director of Research for the Commission, will facilitate the symposium where those preparing papers and others will be presenting.
|
||||
©2007 Commission of Inquiry on Hormone Receptor Testing |